Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies

Neurology

Volumn 53, Issue 9, 1999, Pages 1992-1997

  Andersen, K ^f   Launer, L J ^a   Dewey, M E ^f   Letenneur, L ^b   Ott, A ^a   Copeland, J R M ^f   Dartigues, J F ^b   Kragh Sorensen, P ^f   Baldereschi, M ^c   Brayne, C ^f   Lobo, A ^d   Martinez Lage, J M ^e   Stijnen, T ^a   Hofman, A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b INSERM   (France)

^c CNR   (Italy)

^d UNIVERSITY OF ZARAGOZA   (Spain)

^e UNIVERSITY OF NAVARRA   (Spain)

^f NONE

Author keywords

AD; Dementia; Epidemiology; Incidence study; Vascular dementia

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; PRIORITY JOURNAL; RISK; SEX DIFFERENCE;

EID: 0032786697     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.53.9.1992     Document Type: Article

References (46)

1. Jorm AF, Korten AE, Henderson AS. The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr Scand 1987;76:465-479.
2. Rocca WA, Hofman A, Brayne C, et al. Frequency and distribution of Alzheimer's disease in Europe: a collaborative study of 1980-1990 prevalence findings. The EURODEM-Prevalence Research Group. Ann Neurol 1991;30:381-390.
3. Ritchie K, Kildea D, Robine JM. The relationship between age and the prevalence of senile dementia: a meta-analysis of recent data. Int J Epidemiol 1992;21:763-769.
4. Fratiglioni L, Viitanen M, von Strauss E, Tontodonati V, Herlitz A, Winblad B. Very old women at highest risk of dementia and Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm. Neurology 1997;48:132-138.
5. Brayne C, Gill C, Huppert FA, et al. Incidence of clinically diagnosed subtypes of dementia in an elderly population. Cambridge Project for Later Life. Br J Psychiatry 1995;167: 255-262.
6. Yoshitake T, Kiyohara Y, Kato I, et al. Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study. Neurology 1995;45:1161-1168.
7. Hebert LE, Scherr PA, Beckett LA, et al. Age-specific incidence of Alzheimer's disease in a community population. JAMA 1995;273:1354-1359.
8. Paykel ES, Brayne C, Huppert FA, et al. Incidence of dementia in a population older than 75 years in the United Kingdom. Arch Gen Psychiatry 1994;51:325-332.
9. Bachman DL, Wolf PA, Linn RT, et al. Incidence of dementia and probable Alzheimer's disease in a general population: the Framingham Study. Neurology 1993;43:515-519.
10. Launer LJ, Andersen K, Dewey ME, et al. Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. Neurology 1999;52:78-84.
11. Andersen K, Lolk A, Nielsen H, Andersen J, Olsen C, Kragh-Sørensen P. Prevalence of very mild to severe dementia in Denmark. Acta Neurol Scand 1997;96:82-87.
12. Letenneur L, Commenges D, Dartigues JF, Barberger GP. Incidence of dementia and Alzheimer's disease in elderly community residents of south-western France. Int J Epidemiol 1994;23:1256-1261.
13. Ott A, Breteler MM, van Harskamp F, et al. Prevalence of Alzheimer's disease and vascular dementia: association with education, the Rotterdam Study. BMJ 1995;310:970-973.
14. Saunders PA, Copeland JR, Dewey ME, Larkin BA, Scott A. Alpha: the Liverpool MRC Study of the incidence of dementia and cognitive decline. Neuroepidemiology 1992;11:44-47.
15. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
16. Copeland JR, Kelleher MJ, Kellett JM, et al. A semi-structured clinical interview for the assessment of diagnosis and mental state in the elderly: the Geriatric Mental State Schedule. I. Development and reliability. Psychol Med 1976;6: 439-449.
17. Roth M, Tym E, Mountjoy CQ, et al. CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry 1986;149:698-709.
18. American Psychiatric Association. Diagnostic and statistical manual'of mental disorders. 3rd ed., revised. Washington, DC: American Psychiatric Association, 1987.
19. McKhann G, Drachmann D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
20. SAS Institute. SAS technical report P-243. SAS/STAT software: the Genmod procedure. Cary, NC: SAS Institute Inc., 1993.
21. McLachlan GJ, Krishman T. The EM algorithm and extension New York: John Wiley and Sons, 1997.
22. Hofman A, Rocca WA, Brayne C, et al. The prevalence of dementia in Europe: a collaborative study of 1980-1990 findings. EURODEM Prevalence Research Group. Int J Epidemiol 1991;20:736-748.
23. World Health Organization (WHO). Atlas of mortality in Europe Sub-national patterns 1980/81 and 1990/91. European series no. 75. Geneva: WHO regional publications, 1997.
24. Rocca WA, Cha RH, Waring SC, Kokmen E. Incidence of dementia and Alzheimer's disease: a reanalysis of data from Rochester, Minnesota, 1975-1984. Am J Epidemiol 1998;48: 51-62.
25. Aevarsson O, Skoog I. Dementia disorders in a birth cohort followed from 85 to 88. The influence of mortality, refusal rate, and diagnostic change on prevalence. Int Psychogeriatr 1997;9:11-23.
26. Bowen JD, Malter AD, Sheppard L, et al. Predictors of mortality in patients diagnosed with probable Alzheimer's disease. Neurology 1996;47:433-439.
27. Jagger C, Clarke M, Stone A. Predictors of survival with Alzheimer's disease: a community-based study. Psychol Med 1995;25:171-177.
28. Jagger C, Andersen K, Breteler MMB, et al. Prognosis with dementia: results from a European collaborative analysis of population-based studies. In: Iqbal K, Swaab DF, Winblad B, Wisniewski HM, eds. Alzheimer's disease and related disorders. London: John Wiley & Sons, 1999:39-43.
29. Tombaugh TN, McIntyre NJ. The Mini-Mental State Examination: a comprehensive review. J Am Geriatr Soc 1992;40: 922-935.
30. Shughrue PJ, Dorsa DM. Estrogen modulates the growth-associated protein GAP-43 (Neuromodulin) mRNA in the rat preoptic area and basal hypothalamus. Neuroendocrinology 1993;57:439-447.
31. Naftolin F, Leranth C, Perez J, Garcia Segura LM. Estrogen induces synaptic plasticity in adult primate neurons. Neuroendocrinology 1993;57:935-939.
32. Toran Allerand CM, Miranda RC, Bentham WD, et al. Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain. Proc Natl Acad Sci USA 1992;89:4668-4672.
33. Jaffe AB, Toran Allerand CD, Greengard P, Gandy SE. Estrogen regulates metabolism of Alzheimer amyloid beta precursor protein. J Biol Chem 1994;269:13065-13068.
34. Mooradian AD. Antioxidant properties of steroids. J Steroid Biochem Mol Biol 1993;45:509-511.
35. Bauer J, Ganter U, Strauss S, et al. The participation ot interleukin-6 in the pathogenesis of Alzheimer's disease. Res Immunol 1992;143:650-657.
36. Bishop J, Simpkins JW. Role of estrogens m peripheral and cerebral glucose utilization. Rev Neurosci 1992;3:121-137.
37. Belfort MA, Saade GR, Snabes M, et al. Hormonal status affects the reactivity of the cerebral vasculature. Am J Obstet Gynecol 1995;172:1273-1278.
38. Paganini Hill A, Henderson VW. Estrogen replacement therapy and risk of Alzheimer disease. Arch Intern Med 1996;156: 2213-2217.
39. Tang MX, Jacobs D, Stern Y, et al. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 1996;348:429-432.
40. Barrett-Connor E. Sex differences in coronary heart disease. Why are women so superior? Circulation 1997;95:252-264.
41. Jarvik GP, Wijsman EM, Kukull WA, Schellenberg GD, Yu C, Larson EB. Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease: a case-control study. Neurology 1995;45:1092-1096.
42. Skoog I, Lernfeldt B, Landahl S, et al. 15-Year longitudinal study of blood pressure and dementia. Lancet 1996;347:1141-1145.
43. Ott A, Slooter AJC, Hofman A, et al. Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study. Lancet 1998;351:1840-1843.
44. Payami H, Zareparsi S, Montee KR, et al. Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: a possible clue to the higher incidence of Alzheimer disease in women. Am J Hum Genet 1996;58:803-811.
45. Rao VS, van Duijn CM, Connor Lacke L, Cupples LA, Growdon JH, Farrer LA. Multiple etiologies for Alzheimer disease are revealed by segregation analysis. Am J Hum Genet 1994; 55:991-1000.
46. Bamford J, Sandercock P, Dennis M, et al. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project 1981-1986. J Neurol Neurosurg Psychiatry 1988:1373-1380.